Drugs / Del Nido
last change Aug 2023 re-read 3 minutes ago

Del Nido

Developed for
cardiac valvular defect
Investigated by
Sant Pau Research Institute

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04259515 Jul 2019 → Aug 2023 cardiac valvular defect Sant Pau Research Institute Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Del Nido ClinicalTrials.gov intervention name — accepted as the source's own label NCT04259515 ↗
Route Other “administered antegrade or retrograde” NCT04259515 ↗